Considering that dominant mutations in EXT1 and EXT2 genes cause hereditary multiple exostoses [43] and the EXTL1 gene is expressed at very low levels in brain cells [44], EXTL2 and EXTL3 represent the most promising candidates in this pathway for SRT. The gene discussed is EXTL1; the disease is exostosis.